{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T07:47:25Z","timestamp":1768549645049,"version":"3.49.0"},"posted":{"date-parts":[[2020,10,27]]},"group-title":"Public and Global Health","reference-count":28,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2020,11,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The ISARIC prospective multinational observational study is the largest cohort of hospitalized patients with COVID-19. We present relationships of age, sex, and nationality to presenting symptoms.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>International, prospective observational study of 60\u2370109 hospitalized symptomatic patients with laboratory-confirmed COVID-19 recruited from 43 countries between 30 January and 3 August 2020. Logistic regression was performed to evaluate relationships of age and sex to published COVID-19 case definitions and the most commonly reported symptoms.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\u2018Typical\u2019 symptoms of fever (69%), cough (68%) and shortness of breath (66%) were the most commonly reported. 92% of patients experienced at least one of these. Prevalence of typical symptoms was greatest in 30-to 60-year-olds (respectively 80%, 79%, 69%; at least one 95%). They were reported less frequently in children (\u226418 years: 69%, 48%, 23%; 85%), older adults (\u226570 years: 61%, 62%, 65%; 90%), and women (66%, 66%, 64%; 90%; vs men 71%, 70%, 67%; 93%). The most common atypical presentation under 60 years of age was nausea and vomiting, and over 60 years was confusion. Regression models showed significant differences in symptoms with sex, age and country.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Interpretation<\/jats:title>\n                  <jats:p>Adults over 60 and children admitted to hospital with COVID-19 are less likely to present with typical symptoms. Nausea and vomiting are common atypical presentations under 30 years. Confusion is a frequent atypical presentation of COVID-19 in adults over 60 years. Women are less likely to experience typical symptoms than men.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>Adults over 60 and children admitted to hospital with COVID-19 are less likely to have typical symptoms. Nausea and vomiting are common atypical presentations under 30 and confusion over 60. Women are less likely to experience typical symptoms than men.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2020.10.26.20219519","type":"posted-content","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T17:40:11Z","timestamp":1603820411000},"source":"Crossref","is-referenced-by-count":17,"title":["COVID-19 symptoms at hospital admission vary with age and sex: ISARIC multinational study"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1726-8989","authenticated-orcid":false,"given":"Mark G","family":"Pritchard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"ISARIC Clinical Characterisation Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"issue":"7","key":"2020112111051284000_2020.10.26.20219519v2.1","first-page":"Cd013665","article-title":"Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease","volume":"7","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2020112111051284000_2020.10.26.20219519v2.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"2020112111051284000_2020.10.26.20219519v2.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"issue":"6","key":"2020112111051284000_2020.10.26.20219519v2.4","doi-asserted-by":"crossref","first-page":"2000562","DOI":"10.1183\/13993003.00562-2020","article-title":"Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China","volume":"55","year":"2020","journal-title":"Eur Respir J"},{"key":"2020112111051284000_2020.10.26.20219519v2.5","doi-asserted-by":"crossref","unstructured":"Wang G , Chen W , Jin X , Chen YP . Description of COVID-19 cases along with the measures taken on prevention and control in Zhejiang, China. J Med Virol 2020.","DOI":"10.1002\/jmv.25906"},{"issue":"15","key":"2020112111051284000_2020.10.26.20219519v2.6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/cid\/ciaa330","article-title":"Self-reported olfactory and taste disorders in patients with severe acute respiratory coronavirus 2 infection: A cross-sectional study","volume":"71","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2020112111051284000_2020.10.26.20219519v2.7","doi-asserted-by":"publisher","DOI":"10.1002\/alr.22579"},{"key":"2020112111051284000_2020.10.26.20219519v2.8","unstructured":"Manoharan L , Cattrall JWS , Harris C , Newell K , Thomson B , Pritchard MG , Bannister PG , Sigfrid L , Solomon T , Horby PW , Carson G , Olliaro PL . Early clinical characteristics of Covid-19: scoping review. MedRxiv 2020: 2020.07.31.20165738 [Preprint]. August 4, 2020 [cited 7 August 2020].."},{"key":"2020112111051284000_2020.10.26.20219519v2.9","unstructured":"World Health Organization. WHO COVID-19: Case definitions [WHO\/2019-nCoV\/Surveillance_Case_Definition\/2020.1]. Geneva, Switzerland: World Health Organization; 2020."},{"key":"2020112111051284000_2020.10.26.20219519v2.10","unstructured":"Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19) 2020 interim case definition. 2020 [cited 2020 9 November]; Available from: https:\/\/www.n.cdc.gov\/nndss\/conditions\/coronavirus-disease-2019-covid-19\/case-definition\/2020\/"},{"key":"2020112111051284000_2020.10.26.20219519v2.11","unstructured":"Public Health England. COVID19: investigation and initial clinical management of possible cases. 2020 [cited 2020 9 November]; Available from: https:\/\/www.gov.uk\/government\/publications\/wuhan-novel-coronavirus-initial-investigation-of-possible-cases\/investigation-and-initial-clinical-management-of-possible-cases-of-wuhan-novel-coronavirus-wn-cov-infection"},{"key":"2020112111051284000_2020.10.26.20219519v2.12","unstructured":"European Centre for Disease Prevention and Control. Case definition for coronavirus disease 2019 (COVID-19), as of 29 May 2020. 2020 [cited 2020 9 November]; Available from: https:\/\/www.ecdc.europa.eu\/en\/covid-19\/surveillance\/case-definition"},{"key":"2020112111051284000_2020.10.26.20219519v2.13","unstructured":"International Severe Acute Respiratory and Emerging Infection Consortium, World Health Organization. ISARIC\/WHO Clinical Characterisation Protocol for Severe Emerging Infections, version 3.2: ISARIC; 2020."},{"issue":"7","key":"2020112111051284000_2020.10.26.20219519v2.14","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S1473-3099(20)30440-0","volume":"20","author":"ISARIC clinical characterisation group. Global outbreak research: harmony not hegemony","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2020112111051284000_2020.10.26.20219519v2.15","unstructured":"International Severe Acute Respiratory and Emerging Infection Consortium. COVID-19 CRF. 2020 [cited 21 August 2020]; Available from: https:\/\/isaric.org\/research\/covid-19-clinical-research-resources\/covid-19-crf\/"},{"key":"2020112111051284000_2020.10.26.20219519v2.16","unstructured":"ISARIC 4C. ISARIC 4C protocols. 2020 [cited 26 August 2020]; Available from: https:\/\/isaric4c.net\/protocols\/"},{"key":"2020112111051284000_2020.10.26.20219519v2.17","unstructured":"COVID-19 Critical Care Consortium. COVID-19 Critical Care Consortium Trial Documents. 2020 [cited 26 August 2020]; Available from: https:\/\/www.elso.org\/COVID19\/ECMOCARD.aspx"},{"key":"2020112111051284000_2020.10.26.20219519v2.18","doi-asserted-by":"crossref","unstructured":"Munblit D , Nekliudov NA , Bugaeva P , Blyuss O , Kislova M , Listovskaya E , Gamirova A , Shikhaleva A , Belyaev V , Timashev P , Warner JO , Comberiati P , Apfelbacher C , Bezrukov E , Politov ME , Yavorovskiy A , Bulanova E , Tsareva N , Avdeev S , Kapustina VA , Pigolkin YI , Dankwa EA , Kartsonaki C , Pritchard MG , Victor F , Svistunov AA , Butnaru D , Glybochko P. StopCOVID cohort: An observational study of 3,480 patients admitted to the Sechenov University hospital network in Moscow city for suspected COVID-19 infection. Clin Infect Dis 2020.","DOI":"10.1093\/cid\/ciaa1535"},{"key":"2020112111051284000_2020.10.26.20219519v2.19","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwi017"},{"key":"2020112111051284000_2020.10.26.20219519v2.20","unstructured":"World Bank. World Bank country and lending groups. 2020 [cited; Available from: https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups"},{"issue":"2","key":"2020112111051284000_2020.10.26.20219519v2.21","first-page":"150","article-title":"Assessment and treatment of older individuals with COVID 19 multi-system disease: Clinical and ethical implications","volume":"91","year":"2020","journal-title":"Acta Biomed"},{"issue":"4","key":"2020112111051284000_2020.10.26.20219519v2.22","first-page":"158","article-title":"Atypical clinical presentation of geriatric syndrome in elderly patients with pneumonia or coronary artery disease","volume":"21","year":"2018","journal-title":"Ann Geriatr Med Res"},{"key":"2020112111051284000_2020.10.26.20219519v2.23","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-346"},{"key":"2020112111051284000_2020.10.26.20219519v2.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2005073"},{"key":"2020112111051284000_2020.10.26.20219519v2.25","doi-asserted-by":"publisher","DOI":"10.1111\/apa.15270"},{"key":"2020112111051284000_2020.10.26.20219519v2.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3249"},{"key":"2020112111051284000_2020.10.26.20219519v2.27","doi-asserted-by":"crossref","unstructured":"Millar JE , Neyton L , Seth S , Dunning J , Merson L , Murthy S , Russell CD , Keating S , Swets M , Sudre CH , Spector TD , Ourselin S , Steves CJ , Wolf J , Docherty AB , Harrison EM , Openshaw PJ , Semple MG , Baillie JK . Robust, reproducible clinical patterns in hospitalised patients with COVID-19. MedRxiv 2020: 2020.08.14.20168088 [Preprint]. August 16, 2020 [cited 2 September 2020].","DOI":"10.1101\/2020.08.14.20168088"},{"issue":"6","key":"2020112111051284000_2020.10.26.20219519v2.28","first-page":"501","article-title":"Sex differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders in 1942 nonhospitalized patients with coronavirus disease 2019 (COVID-19)","volume":"130","year":"2020","journal-title":"Pol Arch Intern Med"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2020.10.26.20219519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:57:25Z","timestamp":1768485445000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2020.10.26.20219519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,27]]},"references-count":28,"URL":"https:\/\/doi.org\/10.1101\/2020.10.26.20219519","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s15010-021-01599-5","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2020,10,27]]},"subtype":"preprint"}}